Emergency Number
044 2476 8402 Ext: 379 / 475
Facebook Twitter Instagram linkedin

Doctor Profile - Dr. K. N. Chandan Kumar

Consultant
Dr. K. N. Chandan Kumar

Education:

MBBS, MD (Gen Med), DM (Hepatology)

Area(s) of Specialization:

Acute-on-chronic liver failure, portal hypertension, liver transplantation

Experience:

10 Years Post MD

Consultation days:

Monday to Saturday

Consultation Time:

8.00 am to 4.00 pm

For Appointment, Call:

044-45928500 EXT: 8898

Fellowships / Memberships:

  1. International Liver Transplantation Society (ILTS)
  2. European Association for the Study of the Liver (EASL)
  3. Indian Society of Gastroenterology (ISG)- Lifetime member
  4. Indian Society of Gastroenterology- Tamil Nadu chapter (ISGTN) - Lifetime member
  5. Indian National Association for Study of Liver (INASL) - Lifetime member
  6. Liver Transplantation Society of India (LTSI)- Lifetime member
  7. Indian Medical Association (IMA) - Lifetime member

Publications:

  1. Kedarisetty CK, Anand L, Bhardwaj A et al. Combination of Granulocyte colony stimulating factor and Erythropoieitin improves outcome of patients with decompensated cirrhosis. Gastroenterology 2015 Jun;148(7):1362-1370
  2. Kedarisetty CK, Bhardwaj A, Vashishtha C, Bhadoria A et al. Carvedilol delays the progression of small esophageal varices in patients with cirrhosis. Gut 2016; doi: 10.1136/gutjnl-2016-311735
  3. Bhadoria AS, Kedarisetty CK, Bihari C, Kumar G et al. Impact of family history of metabolic traits on severity of NASH related cirrhosis: a cross-sectional study. Liver International 2017; doi: 10.1111/liv.13396
  4. Anand L, Bihari C, Kedarisetty CK, Rooge SB et al. Early cirrhosis and a preserved bone marrow niche favor regenerative response to growth factors in decompensated cirrhosis. Liver International 2018; doi: 10.1111/liv.13923
  5. Bhadoria AS, Kedarisetty CK, Bhardwaj A et al. Positive family history for metabolic traits predisposes to early and more severe alcoholic cirrhosis: A cross-sectional study. Liver International 2018; doi:10.1111/liv.13958
  6. Varghese J, Kedarisetty CK, Venkataraman J, Srinivasan V et al. Combination of TACE and sorafenib improves outcomes in BCLC stages B/C of Hepatocellular carcinoma: A single center experience. Annals of Hepatology 2017; 16(2):247-254 
  7. Choudhary A, Kedarisetty CK, Vashishtha C et al. A randomised trial comparing terlipressin and noradrenaline in patients with septic shock. Liver International 2017; 37(4):552-561
  8. Maiwall R, Sarin SK, Kumar S, Kedarisetty CK, Abbas Z et al. Development of predisposition, injury, response, organ failure model for predicting acute kidney injury in acute on chronic liver failure. Liver International 2017; doi: 10.1111/liv.13443
  9. Jain M, Varghese J, Kedarisetty CK, Balajee G et al. An insight into antibiotic resistance to bacterial infection in chronic liver disease. Journal of Clinical and Experimental Hepatology 2017; 7 (4): 305- 309
  10. Choudhary A, Bhardwaj A, Kedarisetty CK, Ilan Y, Sarin SK. Methacetin Breath test is superior to MELD in predicting mortality in acute-on-chronic liver failure: Results of a Phase-2 clinical trial. Journal of Hepatology 2016; 64 (2): S228
  11. Maras J, Maiwall R, Kedarisetty CK, Sharma S et al. Dysregulated iron homeostasis is strongly associated with multi-organ failure and early mortality in acute-on-chronic liver failure. Hepatology 2015 Apr;61(4):1306-20
  12. Kedarisetty CK, Sarin SK, Anand L, Abbas Z et al. Liver failure determines the extra-hepatic organ failure and outcome in patients with acute-on-chronic liver failure: Analysis of 1363 patients of AARC database. Hepatology 2014, 60: 556A
  13. Choudhary A, Kedarisetty CK, Vashishtha C, Sarin SK et al. Systemic inflammatory response syndrome (SIRS) — a potential clinical marker for early sepsis and survival in acute on chronic liver failure (ACLF). Hepatology 2014; 60 (Suppl. 1), A476A
  14. Kedarisetty CK, Anand L, Khanam A, Kumar A, Rastogi A, Maiwall R, Sarin SK. Growth factors enhance liver regeneration in acute-on-chronic liver failure. Hepatology International 2014; 8(2): 514- 525
  15. Kumar N, Kedarisetty CK, Kumar S, Khillan V, Sarin SK. Anti-tubercular therapy in patients with cirrhosis: Challenges and options. World Journal of Gastroenterology 2014; 20(19): 5760–5772
  16. Sarin SK, Kedarisetty CK, Abbas Z, Amarapurkar D et al. Acute-on-chronic liver failure: An update on consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Hepatology International 2014; 8: 453- 471

Other Consultants in Hepatology

Hepatology

Board:044-45928500 Ext.no. 8898